Concepedia

Michael Kragh

MK

40

Publications

2.3K

Citations

26

H-Index

1997

Active since

Affiliations

Symphogen (Denmark)(Current)

University of Copenhagen

University of Turin

Hospital Del Mar

Michael Kragh is an author at Symphogen (Denmark) specializing in medicine, tumor biology, and tumor microenvironment.

Top concepts

Publications per year

1997–2020

40

Publications

40

The genomic landscape of response to EGFR blockade in colorectal cancer

Andrea Bertotti, Eniko Papp, Siân Jones et al. · Nature · 2015 · 485 citations · Full text

, , +9

Sym004: A Novel Synergistic Anti–Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy

Mikkel W. Pedersen, Helle J. Jacobsen, Klaus Koefoed et al. · Cancer Research · 2010 · 227 citations

, , +12

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses

Clara Montagut, Guillem Argilés, Fortunato Ciardiello et al. · JAMA Oncology · 2018 · 142 citations · Full text

CD4<sup>+</sup> and CD8a<sup>+</sup> PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models

Lotte K. Kristensen, Camilla Fröhlich, Camilla L. Christensen et al. · Theranostics · 2019 · 104 citations · Full text

Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor

Klaus Koefoed, Lucilla Steinaa, Josefine Nielsen Søderberg et al. · mAbs · 2011 · 92 citations · Full text

, , +21

Rows per page

1–5 of 40